| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQ | Common Stock | Options Exercise | $26,719 | +5,625 | +0.57% | $4.75* | 998,625 | 06 Oct 2021 | Direct | |
| transaction | EQ | Common Stock | Sale | $39,418 | -5,625 | -0.56% | $7.01* | 993,000 | 06 Oct 2021 | Direct | F1, F2 |
| transaction | EQ | Common Stock | Options Exercise | $6,908 | +2,467 | +0.25% | $2.80 | 995,467 | 06 Oct 2021 | Direct | |
| transaction | EQ | Common Stock | Sale | $17,288 | -2,467 | -0.25% | $7.01* | 993,000 | 06 Oct 2021 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQ | Employee Stock Option (right to buy) | Options Exercise | $0 | -5,625 | -100% | $0.000000* | 0 | 06 Oct 2021 | Common Stock | 5,625 | $4.75 | Direct | F4 |
| transaction | EQ | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,467 | -100% | $0.000000* | 0 | 06 Oct 2021 | Common Stock | 2,467 | $2.80 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| F4 | This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter. |
| F5 | This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter. |